ArticleOncotarget2016

Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers.

Hamid H Gari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.